BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

ViiV Healthcare has secured FDA Priority Review for its application [...]

Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

The US Food and Drug Administration (FDA) has accepted for [...]